As of May 29, 2025, Nascent Biotech Inc (NBIO) reports a Net Margin of -47.00%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Nascent Biotech Inc's Net Margin
Over recent years, Nascent Biotech Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2023-03-31 | -47.00% |
| 2022-03-31 | -47.00% |
| 2021-03-31 | -128.00% |
| 2020-03-31 | 38.00% |
This fluctuation highlights how Nascent Biotech Inc manages its overall profitability and cost control over time.
Comparing Nascent Biotech Inc's Net Margin to Peers
To better understand Nascent Biotech Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Nascent Biotech Inc (NBIO) | -47.00% |
| BigString Corp (BSGC) | 1061.30% |
| Encounter Technologies Inc (ENTI) | 1.19% |
| Initio Inc (INTO) | -7.19% |
| On4 Communications Inc (ONCI) | -124.10% |
| JPO Solutions Inc (MOPN) | -156.52% |
Compared to its competitors, Nascent Biotech Inc's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.